OTCM
MNIVF
Market cap194mUSD
, Last price
Name
Monash IVF Group Ltd
Chart & performance
P/E
—
P/S
—
EPS
0.02
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
7.97%
Div Yld LY
—
Div Yld TTM
—
Revenues
269m
-0.90%
Net income
7m
-70.31%
CFO
30m
+134.11%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Founded in 2014 and headquartered in Richmond, Australia, Monash IVF Group Limited delivers specialized reproductive assistance and women's imaging services. Its operations span Australia and Malaysia, offering a broad spectrum of care. This includes diagnostic obstetric and gynecological ultrasound examinations, a range of fertility treatments, and advanced tertiary-level prenatal diagnostics. The company is also a key provider of in-vitro fertilization (IVF) services.
Key people
Non-Executive Independent Chairman of the Board · since 2014
Victoria Atkinson
Chief Executive Officer, Managing Director, Director · since 2026
Interim Chief Financial Officer · since 2025
Rebecca Redden
Chief Operating Officer · since 2025
Richard Henshaw
Executive Director · since 2014
Catherine Aston
Non-Executive Independent Director · since 2024
Neil Broekhuizen
Non-Executive Independent Director · since 2014
Dwayne Crombie
Non-Executive Independent Director · since 2025
Non-Executive Independent Director · since 2016
Non-Executive Independent Director · since 2020
IPO date
Jun 26, 2014
Employees
867
Domiciled in
AU
Incorporated in
AU
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||